State Street’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.1M | Buy |
|
|||||
2025
Q1 | $22.8M | Sell |
|
|||||
2024
Q4 | $25.1M | Buy |
|
|||||
2024
Q3 | $32.2M | Buy |
|
|||||
2024
Q2 | $49.7M | Sell |
|
|||||
2024
Q1 | $76.2M | Buy |
|
|||||
2023
Q4 | $47.5M | Buy |
|
|||||
2023
Q3 | $4.6M | Sell |
|
|||||
2023
Q2 | $7.72M | Buy |
|
|||||
2023
Q1 | $4.82M | Sell |
|
|||||
2022
Q4 | $34.2M | Buy |
|
|||||
2022
Q3 | $33M | Buy |
|
|||||
2022
Q2 | $6.95M | Sell |
|
|||||
2022
Q1 | $37.9M | Buy |
|
|||||
2021
Q4 | $37.8M | Buy |
|
|||||
2021
Q3 | $51.8M | Buy |
|
|||||
2021
Q2 | $59.9M | Buy |
|
|||||
2021
Q1 | $55.4M | Buy |
|
|||||
2020
Q4 | $8.89M | Buy |
|
|||||
2020
Q3 | $3.7M | Buy |
|
|||||
2020
Q2 | $6.25M | Buy |
|
|||||
2020
Q1 | $30K | Sell |
|
|||||
2019
Q4 | $53K | Sell |
|
|||||
2019
Q3 | $27K | Buy |
|
|||||
2019
Q2 | $22K | Sell |
|
|||||
2019
Q1 | $654K | Buy |
|
|||||
2018
Q4 | $477K | Sell |
|
|||||
2018
Q3 | $1.52M | Buy |
|
|||||
2018
Q2 | $1.25M | Buy |
|
|||||
2018
Q1 | $1.56M | Buy |
|
|||||
2017
Q4 | $1.65M | Buy |
|
|||||
2017
Q3 | $1.95M | Buy |
|
|||||
2017
Q2 | $2.59M | Buy |
|
|||||
2017
Q1 | $791K | Buy |
|
|||||
2016
Q4 | $1.1M | Buy |
|
|||||
2016
Q3 | $1.19M | Buy |
|
|||||
2016
Q2 | $843K | Buy |
|
|||||
2016
Q1 | $1.02M | Buy |
|
|||||
2015
Q4 | $1.75M | Buy |
|
|||||
2015
Q3 | $485K | Buy |
|